Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
3 citing papers in PubMed, 1 synthesis or guideline pooled it.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
13 authors.
Anastasiia A BuianovaThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.
Marina V BazanovaFSBI 'The National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of Russia', 123182 Moscow, Russia.
Vera A BelovaThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.ORCID 0000-0001-5930-1965
Galit A IlyinaThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.
Alina F SamitovaThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.ORCID 0009-0001-8941-7034
Anna O ShmitkoThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.ORCID 0000-0001-5256-0892
Anna V BalakinaFSBI 'The National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of Russia', 123182 Moscow, Russia.
Anna S PavlovaThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.
Oleg N SuchalkoThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.
Dmitriy O KorostinThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.ORCID 0000-0003-1343-2550
Anton S MachalovFSBI 'The National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of Russia', 123182 Moscow, Russia.
Nikolai A DaikhesFSBI 'The National Medical Research Center for Otorhinolaryngology of the Federal Medico-Biological Agency of Russia', 123182 Moscow, Russia.
Denis V RebrikovThe Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, 117513 Moscow, Russia.
Funding
Ministry of Science and Higher Education of the Russian Federation №075-15-2019-1789
6 · The paper itself
Abstract
Auditory neuropathy spectrum disorder (ANSD) is often missed by standard hearing tests, accounting for up to 10% of hearing impairments (HI) and commonly linked to variants in 23 genes. We assessed 122 children with HI, including 102 with sensorineural hearing loss (SNHL) and 20 with ANSD. SNHL patients were genotyped for common
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Heterogeneous Group of Genetically Determined Auditory Neuropathy Spectrum Disorders. · full record | OpenQuestion